Evidence map›Paper›PMID 40625200›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Aberrant Mitochondrial Metabolism in Alzheimer's Disease Links Energy Stress with Ferroptosis.

Francesca Alves, Darius Lane, Adam Wahida, Md Jakaria, Pawel Kalinowski, Adam Southon, Abdel Ali Belaidi, Teresa Samperi-Esteve, Triet Phu Minh Nguyen, Peng Lei and 8 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Inhibition of Ferroptotic Toxicity by 4-Hydroxyindole.Chemical research in toxicology · 2025
    Article
  10. Aberrant Mitochondrial Metabolism in Alzheimer's Disease Links Energy Stress with Ferroptosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Francesca AlvesThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.ORCID https://orcid.org/0000-0002-9059-3238
Darius LaneThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.ORCID https://orcid.org/0000-0001-8725-6903
Adam WahidaHelmholtz Zentrum München, Institute of Metabolism and Cell Death, 85764, Neuherberg, Germany.ORCID https://orcid.org/0000-0002-8856-8834
Md JakariaThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.
Pawel KalinowskiThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.
Adam SouthonThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.
Abdel Ali BelaidiThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.
Teresa Samperi-EsteveNew Therapeutic Targets Group (TargetsLab), Department of Medical Science, Faculty of Medicine, University of Girona, Girona, 17003, Spain.
Triet Phu Minh NguyenThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.
Peng LeiDepartment of Neurology and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
Marcus KruegerInstitute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), 50931, Cologne, Germany.
Stefan MuellerCECAD/CMMC Proteomics Facility, Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
Marcus ConradHelmholtz Zentrum München, Institute of Metabolism and Cell Death, 85764, Neuherberg, Germany.
Puja AgarwalRush Alzheimer Disease Center, Rush University Medical Center, Chicago, 60612, USA.
Sue E LeurgansRush Alzheimer Disease Center, Rush University Medical Center, Chicago, 60612, USA.
Julie SchneiderRush Alzheimer Disease Center, Rush University Medical Center, Chicago, 60612, USA.
Ashley I BushThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.
Scott AytonThe Florey Institute of Neuroscience and Mental Health, Melbourne, 3052, Australia.ORCID https://orcid.org/0000-0002-3479-2427

Funding

Neuropathologic-Epidemiological Study of Metallomics and Alzheimer's DiseaseR01AG054057 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI Julie A. Schneider · 2022 to 2026
$3.0M
National Health and Medical Research Council GNT1194028National Health and Medical Research Council GNT2008359NIA NIH HHS 2R01AG054057-02NIA NIH HHS R01 AG054057
6 · The paper itself

Abstract

Alzheimer's disease (AD) is defined by β-amyloid plaques and tau-containing neurofibrillary tangles, but the ensuing cellular derangements that culminate in neurodegeneration remain elusive. Here, a mechanistic link between two AD pathophysiological hallmarks: energy insufficiency and oxidative stress is revealed. It is demonstrated that mitochondrial function and glutathione (GSH) flux are coupled, impacting neuronal ferroptosis susceptibility. Analysis of proteomic data from the inferior temporal cortex of 625 subjects along a continuum of clinical and pathological changes in AD, reveals a prominent depletion of mitochondrial proteins. Biogenetic insufficiency in AD is reflected by a concurrent loss of GSH, which requires 2 ATP for its synthesis, and genetic and pharmacologic ATP depletion models confirm that ATP is rate-limiting for GSH. Accordingly, an unbiased association analysis uncovers mitochondrial proteins in positive correlation with total GSH (t-GSH) in AD subjects. But mitochondria also consume GSH via the SLC25A39 transporter. It is found that mitochondrial inhibition either increases or decreases ferroptosis susceptibility in cellular models, depending on contextual factors that dictate whether mitochondria act as a net GSH producer or consumer, respectively. Mitochondria therefore control GSH flux, and loss of energy output is consequently demonstrated as a liability for ferroptosis in AD.

Indexed as

Alzheimer DiseaseEnergy MetabolismFerroptosisMitochondriaAgedFemaleGlutathioneHumansMaleOxidative StressGlutathionealzheimer's diseaseATPbioenergeticsferroptosisglutathionemitochondrianeurodegeneration

Identifiers

PMID40625200
PMCPMC12499490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.